Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Optimizing Treatment Outcomes for Patients With Depression and Generalized Anxiety Disorder
1
x
$
30.00
Divalproex in the Treatment of Migraine
1
x
$
30.00
Ken Gersing, MD: Predicting Antipsychotic Use in Children
1
x
$
30.00
Characteristics of Inpatients Prescribed Dopamine Receptor Blocking Agents
1
x
$
30.00
Laszlo Gyulai - Correlates of Functioning in Bipolar Disorder
1
x
$
30.00
Possible Lurasidone-Associated Dose-Dependent QTc Prolongation in First-Episode Psychosis
1
x
$
30.00
Efficacy of High-Dose Aripiprazole for Treatment-Resistant Schizoaffective Disorder: A Case Report
1
x
$
30.00
Resúmenes recientes del XXI Congreso Latinoamericano de Psiquiatria/XVI Congreso Nacional de Psiquiatría, Lima, Perú en Psiquiatría, Neurología, y Medicina General
1
x
$
0.00
Mark Zetin, MD: Rational Antidepressant Selection: Applying Evidence-Based Medicine to Complex Real-World Patients
1
x
$
30.00
Johannes Hamann, MD: How Long do Psychiatrists Wait for Response Before They Switch to Another Antipsychotic?
1
x
$
30.00
Pharmacokinetics, Drug Interactions, and Tolerability of Valproate
1
x
$
30.00
VOL 3 No. 7 Full Issue - July 2001
1
x
$
20.00
VOL 3 No. 6 Full Issue - June 2001
1
x
$
20.00
View Cart
Checkout
Home
Store
“VOL 3 No. 6 Full Issue – June 2001” has been added to your cart.
View cart
Sort by
Name
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Divalproex in the Treatment of Migraine
$
30.00
Add to cart
Details
Do Long-Acting Injectable Antipsychotics Prevent or Delay Hospital Readmission?
$
30.00
Add to cart
Details
Does Isotretinoin Cause Depression and Suicide? By J. Douglas Bremner, MD
$
0.00
Add to cart
Details
Donald S. Robinson, MD: Monoamine Oxidase Inhibitors: A New Generation
$
30.00
Add to cart
Details
Donald S. Robinson, MD: Treatment Effects of Selegiline Transdermal System on Symptoms of Major Depressive Disorder: A Meta-Analysis of Short-Term, Placebo-Controlled, Efficacy Trials
$
30.00
Add to cart
Details
Dose-Dependent Urinary Incontinence with Sertraline Use in Obsessive-Compulsive Disorder
$
30.00
Add to cart
Details
Douglas G. Kondo, MD: An Evidence-Based Medicine Approach to Combined Treatment for ADHD in Children and Adolescents
$
30.00
Add to cart
Details
Dr. Juan E. Mezzich y Dr. Miguel R. Jorge: ¡Bienvenidos a Psiquiatría y Salud Integral!
$
0.00
Add to cart
Details
Drug Development for Anxiety Disorders: New Roles for Atypical Antipsychotics
$
30.00
Add to cart
Details
Drug Induced Mania in a Boy with High Functioning Autism
$
30.00
Add to cart
Details
Drug–Drug Interactions Associated with Second-Generation Antipsychotics: Considerations for Clinicians and Patients
$
30.00
Add to cart
Details
Duloxetine for the Treatment of Major Depressive Disorder
$
30.00
Add to cart
Details
Duloxetine in Military Posttraumatic Stress Disorder
$
30.00
Add to cart
Details
Duration of Untreated Illness in Obsessive-Compulsive Disorder and its Associated Factors
$
30.00
Add to cart
Details
E. Chris Muly, MD, PhD: Signal Transduction Abnormalities in Schizophrenia: the cAMP System
$
30.00
Add to cart
Details
Early Positive Report of Viloxazine for a Child with Hyperkinetic Autism
$
30.00
Add to cart
Details
Early-Life Adversity, CRF Dysregulation, and Vulnerability to Mood and Anxiety Disorders
$
30.00
Add to cart
Details
Economic Impacts of Anxiety Disorders
$
0.00
Add to cart
Details
Economics of Cancer Drug Development
$
0.00
Add to cart
Details
EDITOR’S LETTER: Charles B. Nemeroff, MD, PhD
$
0.00
Add to cart
Details
Previous
1
…
11
12
13
…
44
Next
Page load link
Go to Top
